Apontis Pharma AG (APPH) — Cash Flow Reinvestment Rate
Apontis Pharma AG (APPH) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting €5.60K (capex €5.60K ) from operating cash flow of €905.24K. Explore APPH capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apontis Pharma AG Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Apontis Pharma AG across 3 annual periods. Also explore total assets of Apontis Pharma AG for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Apontis Pharma AG (2020–2022)
Year-by-year capital reinvestment analysis for Apontis Pharma AG. For live market cap and broader valuation context, see Apontis Pharma AG market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.54x | €5.96 Million | €11.02 Million | €3.28 Million | ▼ -45.9% |
| 2021 | 1.00x | €3.43 Million | €3.43 Million | €1.66 Million | ▼ -3.7% |
| 2020 | 1.04x | €1.51 Million | €1.45 Million | €729.56K | — |